Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS
|
|
- Verity Thomas
- 5 years ago
- Views:
Transcription
1 UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN TYPE: o Blood PATIENT IDENTIFICATION (3) (4) PLEASE COLLECT 5-10CC IN ACD-A OR EDTA TUBE ORDERING PHYSICIAN NAME AND PHONE NUMBER: Tests can be ordered as a full panel, or by individual gene(s). Please contact the genetic counselor with any questions at or by pager at Test Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS 2- Methyl- 3- hydroxybutyric aciduria 2- Methylbutyryl- CoA dehydrogenase ACADSB 3- Hydroxy 3- methylglutaric aciduria HMGCL 3- hydroxyacyl- CoA dehydrogenase HADH 3- hydroxyisobutryl- CoA hydrolase HIBCH 3- Methylcrotonyl- CoA carboxylase MCCC1 MCCC2 3- methylglutaconic aciduria (other types) II TAZ 3- methylglutaconic aciduria (other types) III OPA3 3- methylglutaconic aciduria (other types) V DNAJC19 3- Methylglutaconic aciduria type I AUH Acatalasemia CAT Acid- labile subunit, of IGFALS Alkaptonuria HGD alpha subunit of the succinate- CoA ligase enzyme (mito depletion w/ methylmalonic acidemia) SUCLA2 Alpha- methylacetoacetic aciduria Aminoacylase 1 ACY1 Arginemia ARG1 Argininosuccinate acidemia ASL ASPARAGINE SYNTHETASE DEFICIENCY ASNS Aspartylglycosaminuria AGA beta subunit of the succinate- CoA ligase enzyme (mito depletion w/ methylmalonic acidemia SUCLG1 Beta- ureidopropionase UPB1 BIOTINIDASE BTD HLCS Calcification of joints and arteries NT5E Canavan disease ASPA Carboxylesterase 1 CES1 Carnitine acetyltransferase Carnitine acylcarnitine translocase SLC25A20 Carnitine palmitoyltransferase CPT1A CPT2 Carnitine uptake defect Cerebral creatine 1 SLC6A8 Chylomicron retention disease SAR1B Submit this form along with the appropriate Molecular requisition (Molecular Diagnostics or Molecular NGS Oncology). Citrullinemia ASS1 SLC25A13 Coenzyme Q10 COQ2 PDSS1 PDSS2 ADCK3 COQ9 COQ6 Combined malonic and methylmalonic aciduria ACSF3 D- 2- hydroxyglutaric aciduria D2HGDH IDH2 D- glyceric aciduria GLYCTK Defects of biopterin cofactor regeneration PCBD1 PTS Deficiency of butyrylcholine esterase BCHE Dienoyl- CoA reductase DECR1 Dihydrolipoamide dehydrogenase DLD Dihydropyrimidine dehydrogenase DPYD Dihydropyrimidinuria DPYS Dimethylglycine dehydrogenase DMGDH
2 Dopamine beta- hydroxylase DBH DRD BH4 SYNTHESIS SPR Epsilon- trimethyllysine hydroxylase TMLHE Ethylmalonic encephalopathy ETHE1 Familial Hyperinsulinemia ABCC8 KCNJ11 Folate malabsorption, hereditary SLC46A1 Fructose intolerance ALDOB Fructose- 1,6- bidphosphatase FBP1 Galactosemia GALK1 GALE GALT Galactosialidosis CTSA Glutamate formiminotransferase FTCD Glutamine, congenital GLUL Glutaric academia ETFA ETFB ETFDH GCDH Glutathione synthetase GSS Glycerol kinase GK Glycine encephalopathy GCSH GLDC Glycine N- methyltransferase GNMT Glycogen storage disease GYS1 G6PC SLC37A4 GAA AGL GBE1 PHKG2 PHKA1 PYGM PYGL PFKM PGAM2 LDHA ALDOA ENO3 PGM1 GYG1 PHKB GYS2 PHKA2 PIGM Glycosylphosphatidylinositol PIGM Heme oxygenase- 1 HMOX1 Hereditary orotic aciduria UMPS HMG- CoA synthase- 2 HMGCS2 HOMOCYSTEINURIA CBS MTHFR Hypercarotenemia and vitamin A, autosomal dominant BCMO1 Hyperglycinuria SLC6A20 Hyperhomocystinemia - methionine synthase reductae - cble MTRR Hyperhomocystinemia - methionine synthase- cbl G MTR Hyperinsulinism- hyperammonemia GLUD1 Hyperlysinemia AASS Hypermethioninemia due to adenosine kinase ADK Hypermethioninemia with of S- adenosylhomocysteine hydrolase AHCY Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III MAT1A Hyperphe/biopterin metabolism QDPR PCBD1 PAH SPR Hyperoxaluria, primary, type III HOGA1 Hypoglycemia ABCC8 ACAT2 AGL ALDOA ENO3 G6PC GAA GBE1 GYS1 GYS2 KCNJ11 LDHA OXCT1 PFKM PGAM2 PGM1 PHKA1 PHKA2 PHKB PHKG2 PYGL PYGM SLC37A4 hypophosphotasia ALPL Isobutyryl- CoA dehydrogenase ACAD8 ISOVALERIC ACIDEMIA IVD L- 2- hydroxyglutaric aciduria L2HGDH Lactase, congenital LCT Lactate dehydrogenase- B LDHB LCHAD Leukotriene C4 synthase LTC4S
3 Lysinuric protein intolerance SLC7A7 Malonyl- CoA decarboxylase MLYCD Maple syrup urine disease BCKDHA BCKDHB DBT MCAD ACADM Methylmalonate semialdehyde dehydrogenase ALDH6A1 Methylmalonic acidemia MCEE MMADHC LMBRD1 MUT MMAA MMAB ABCD4 Mevalonic aciduria MVK mitochondrial acetoacetyl- CoA thiolase Molybdenum cofactor A MOCS1 MOCS2 GPHN N- acetylaspartate NAT8L N- terminal acetyltransferase NAA10 Non- ketotic hyperglycinemia AMT Norum disease LCAT PEPCK, mitochondrial PCK2 PKU PAH Phosphoenolpyruvate carboxykinase- 1, cytosolic, PCK1 Phosphoglycerate dehydrogenase PHGDH Phosphoglycerate kinase 1 PGK1 Phosphoserine aminotransferase PSAT1 Phosphoserine phosphatase PSPH Prolidase PEPD Propionicacidemia PCCA PCCB Pyruvate dehydrogenase lipoic acid synthetase LIAS Riboflavin SLC52A1 Ribose 5- phosphate isomerase RPIA AICA- ribosiduria due to ATIC ATIC Rickets SLC34A3 DMP1 FGF23 ENPP1 PHEX VDR CYP2R1 CYP27B1 SBCAD ACADSB SCAD ACADS Succinic semialdehyde dehydrogenase ALDH5A1 Sucrase- isomaltase, congenital SI Sulfite oxidase SUOX Thiamine metabolism dysfunction 2 (biotin- or thiamine- responsive encephalopathy type 2) SLC19A3 Thiamine metabolism dysfunction 5 (episodic encephalopathy type) TPK1 Transaldolase TALDO1 transcobalamin receptor (TCBlR) (transcobalamin transport issue) CD320 Trifunctional protein HADHB Trimethylaminuria FMO3 Tumoral calcinosis, hyperphosphatemic, familial GALNT3 Tyrosinemia FAH TAT HPD Urea Cycle ARG1 ASL CPS1 ASS1 NAGS OTC Urocanase UROC1 VLCAD ACADVL Xanthinuria, type I XDH
4 Nuclear mitochondrial genes 3- Methylcrotonyl- CoA carboxylase 1 MCCC1 3- Methylcrotonyl- CoA carboxylase 2 MCCC2 3- methylglutaconic aciduria, type I AUH ACAD9 ACAD9 Acetyl- CoA carboxylase ACACA Acetyl- CoA carboxylase ACACB Argininemia ARG1 Autosomal Recessive Spastic Ataxia with Leukoencephalopathy MARS2 Barth TAZ Biotinidase BTD Carbamoylphosphate synthetase I CPS1 Carnitine, systemic primary Carnitine- acylcarnitine translocase SLC25A20 Charcot- Marie- Tooth disease, recessive intermediate, B KARS Citrullinemia, type II SLC25A13 Coenzyme Q10, primary, 1 COQ2 PDSS1 PDSS2 ADCK3 COQ9 Combined oxidative phosphorylation GFM1 MTO1 EARS2 FARS2 MTFMT ELAC2 MRPS16 TSFM TUFM MRPS22 C12orf65 AARS2 MRPL3 Congenital disorder of glycosylation MPI PMM2 CPT CPT1B CPT1A CPT2 cytochrome c oxidase SCO2 COX15 COX6B1 COX4I1 COX7A1 COX14 Dihydrolipoamide dehydrogenase DLD Ethylmalonic encephalopathy ETHE1 Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis COX4I2 Glutaric acidemia ETFA ETFB ETFDH Glycogen storage disease GYS1 G6PC SLC37A4 GAA AGL GBE1 PHKG2 PYGL PFKM PGAM2 PGM1 GYS2 PHKA2 PYGM PHKA1 PHKB Hepatic failure, early onset, and neurologic disorder SCO1 Holocarboxylase synthetase HLCS Homocystinuria- megaloblastic anemia, cbl E type MTRR Hyperornithinemia- hyperammonemia- homocitrullinemia SLC25A15 Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis SARS2 Isovaleric acidemia IVD Lacticacidemia due to PDX1 PDHX Leigh BCS1L NDUFA10 NDUFAF2 NDUFS4 NDUFS7 SDHA COX15 FOXRED1 NDUFA12 NDUFA2 NDUFA9 NDUFAF6 NDUFS3 NDUFS8 SURF1 LRPPRC PDHA1 Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation DARS2 Liver failure, transient infantile TRMU Methylmalonic aciduria MMACHC MMADHC LMBRD1 MUT MMAA MMAB Mitochondrial complex 1 NDUFAF5 FOXRED1 NDUFA1
5 NDUFA10 NDUFA11 NDUFAF1 NDUFAF3 NDUFB3 NDUFB9 NDUFS1 NDUFS2 NDUFS3 NDUFS4 NDUFS6 NDUFV1 NDUFV2 NUBPL Mitochondrial complex II SDHAF1 Mitochondrial complex III BCS1L TTC19 UQCRB UQCRQ Mitochondrial complex IV COA5 FASTKD2 TACO1 Mitochondrial complex V (ATP synthase) ATPAF2 TMEM70 ATP5E Mitochondrial DNA depletion TYMP AGK SLC25A4 TK2 DGUOK POLG SUCLA2 MPV17 C10orf2 RRM2B SUCLG1 Mitochondrial myopathy and sideroblastic anemia 1 PUS1 Mitochondrial phosphate carrier SLC25A3 Mohr- Tranebjaerg / Jensen TIMM8A Multiple mitochondrial dysfunctions NFU1 BOLA3 Myoglobinuria, acute recurrent, autosomal recessive LPIN1 Myopathy with lactic acidosis, hereditary ISCU Myopathy, lactic acidosis, and sideroblastic anemia 2 YARS2 N- acetylglutamate synthase NAGS Deafness, autosomal recessive 89 KARS Alpha- methylacetoacetic aciduria LCAD ACADL MCAD ACADM Optic atrophy OPA3 OPA1 Ornithine transcarbamylase OTC Paragangliomas SDHAF2 SDHC SDHB Perrault HARS2 LARS2 Pontocerebellar hypoplasia RARS2 Progressive external ophthalmoplegia SLC25A4 POLG2 RRM2B C10orf2 Propionicacidemia PCCB PCCA Pyruvate carboxylase PC Pyruvate dehydrogenase E1- alpha PDHA1 Pyruvate dehydrogenase E1- beta PDHB Pyruvate dehydrogenase E2 DLAT Pyruvate dehydrogenase phosphatase PDP1 Spastic paraplegia 55, autosomal recessive C12orf65 Thiamine metabolism dysfunction 4 SLC25A19 Transcobalamin II TCN2 Trifunctional protein HADHB Additional nuclear mitochondrial genes MRRF NARS2 NDUFA13 NDUFA4 NDUFA6 NDUFA7 NDUFA8 NDUFAF2 NDUFAF7 NDUFB1 NDUFB6 NDUFC2 NDUFS5 NDUFV3 TFAM TFB1M
6 Fatty acid oxidation Disorders CPT CPT1B CPT1A CPT2 ACAD9 ACAD9 ACADL ACADL Acyl- CoA dehydrogenase, medium chain, of ACADM Acyl- CoA dehydrogenase, short- chain, of ACADS Barth TAZ Carnitine, systemic primary Carnitine- acylcarnitine translocase SLC25A20 LCHAD / Trifunctional protein Myoglobinuria, acute recurrent, autosomal recessive LPIN1 Trifunctional protein HADHB VLCAD ACADVL Lysosomal disease Alpha Mannosidosis MAN2B1 Alpha NAGA NAGA Combined SAP Fabry disease GLA Free Sialic Acid Storage SLC17A5 Fucosidosis FUCA1 Gaucher GBA Gaucher disease, atypical GM1 gangliosidosis GLB1 GM2 gangliosidosis AB variant GM2A Hunter IDS Hurler IDUA I cell disease GNPTAB Krabbe GALC Krabbe disease, atypical Lysosomal Acid Lipase LIPA Mannosidosis, beta MANBA Maroteaux Lamy ARSB Metachromatic leukodystrophy ARSA Metachromatic leukodystrophy due to SAP- b Morquio A GALNS Mucopolysaccharidosis type IVB (Morquio) GLB1 Mucolipidosis IV MCOLN1 Mucopolysaccharidosis type IX HYAL1 Multiple sulfatase SUMF1 Niemann- Pick disease, type A/B SMPD1 Niemann- Pick disease, type C1, type D NPC1 Niemann- pick disease, type C2 NPC2 Mucopolysaccharidisis type IIIA (Sanfilippo A) SGSH Mucopolysaccharidosis type IIIB (Sanfilippo B) NAGLU Mucopolysaccharidosis type IIIC (Sanfilippo C) HGSNAT Mucopolysaccharidosis type IIID / San Filippo D GNS Sandhoff disease HEXB Sialidosis NEU1 Sly GUSB Tay Sachs HEXA
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA,
More informationINVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS
INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening
More informationDiagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationMitochondrial Disorders Genetic Testing
Mitochondrial Disorders Genetic Testing A Comprehensive Guide 1 Introduction Mitochondrial disorders are a group of related, clinically diverse, genetic diseases with a prevalence of 1/5,000 to 1/8,500
More informationBROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationdevact TM Clinical Management Panel for Neurodevelopmental Disorders
Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy
More informationA. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia
OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR
More informationAll diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationBabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related
Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy
More informationJoshua Hellmann Foundation - Newborn Metabolic Screening Program
Joshua Hellmann Foundation - Newborn Metabolic Screening Program Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Last update: 11 June 2013 Target inborn errors of metabolism (IEM)
More informationFor Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationSubject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:
TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential
More informationSema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations
Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered
More informationN.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017
Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml
More informationMISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING Protecting your newborn MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES [ 1 ] NEWBORN SCREENING [ 2 ] FREQUENTLY ASKED QUESTIONS [ 4 ] DISORDERS INCLUDED IN NEWBORN SCREENING [ 12 ]
More informationWhen users open the application interface, the starting page presents a disclaimer. Upon agreeing to the
Walkthrough of IEMbase When users open the application interface, the starting page presents a disclaimer. Upon agreeing to the disclaimer, users are directed to the main page, which presents a search
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD
More informationNEWBORN SCREENING. health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES
NEWBORN SCREENING health.mo.gov/newbornscreening MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES Table of Contents NEWBORN SCREENING...1 FREQUENTLY ASKED QUESTIONS...2 DISORDERS INCLUDED IN NEWBORN SCREENING...4
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationMetabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen
Metabolic Disorders ed Overseas but not ed in Australia Biotinidase Deficiency Severe form causes seizures & delay Biotin can prevent complications NZ, USA Tyrosinaemia Type I Coma & death before age 10
More informationNEWBORN SCREENING. in Massachusetts: Answers for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Answers for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationMetabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius
Metabolic Changes in ASD Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius 12 patients 3 Autism: Ages 3/3/3.7 3 PDD: Ages 3/3/6 3 Asperger: Ages 6/7/15.1 3 Speech delay and Sensory Problems (SHL):
More informationNewborn Genetic Analysis
Fulgent tics Newborn tic Analysis Newborn tic Analysis (NGA) is a highly sophisticated and sensitive genetic test that identifies DNA changes that can cause infants to develop severe or life-altering conditions.
More informationMost common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.
Newborn Screening Examination parameters: TSH-neonatal (hypothyreosis), 17-OH progesterone (AGS), galactose (galactosemia), galactose-uridyl transferase (galacto semia), biotinidase (biotinidase ), phenylalanine
More informationEvolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationHigh Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationTable S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database
Table S5. Disease pairs that have a significant comorbidity and are connected in either KEGG or BiGG database Coincide nce Expected coincidence Maximum possible comorbidity Disease1 Disease2 Link(KEGG)
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationPRICE AND TEST LIST January 4, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6,900.00 81415, 81416,
More informationInborn Errors of Metabolism (IEM)
Clinical Presentation Inborn Errors of Metabolism (IEM) Click on the following: - Clinical Pearl - link to movie clip - link to picture Investigations Blood Work Urine No Acidosis NH 4 + Metabolic Acidosis
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationHA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up
HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up Dr. Josephine Chong Clinical Professional Consultant Centre of Inborn Errors
More informationINBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides
INBORN ERRORS OF METABOLISM (IEM) 1 OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management
More informationPRICE AND TEST LIST August 24, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE
More informationCLINICAL AND HUMAN TESTING
CLINICAL AND HUMAN TESTING CARRIER SCREENING FOR FAMILY PLANNING Let knowledge be your guide. Identify genetic conditions before or during a pregnancy to help predict the chances of having a child with
More informationNEWBORN SCREENING. in Massachusetts: Information for You and Your Baby. University of Massachusetts Medical School
University of Massachusetts Medical School NEWBORN SCREENING in Massachusetts: Information for You and Your Baby New England Newborn Screening Program Biotech 4, 2nd Floor UMass Medical School 377 Plantation
More informationMetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy
Introduction MetBioNet Best Practice Guidelines Investigation of an inherited metabolic cause of Inborn errors of metabolism (IEM) account for at least 5% of cases of. In some disorders, is the major cause
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationPatient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationGenética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD
Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD April 24, 2017 SAP 2017 Buenos Aires Genetic disorders are rare why
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More informationPromo Code (if applicable) mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
tic Diagnostics A. Analysis Requested 1. Test(s)/(s) 1.1 Single Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis B. Patient Name (Label) 1. Surname Promo
More informationNGS Panel Plus. Sequencing Sequencing + NGS based CNVs Del/Dup with MLPA. Clinic. Department. Street. ZIP Code/Town. Country. . Billing.
Promo Code (if applicable) Genetic Diagnostics (s)/gene(s)/panel(s): Analysis Requested Single Gene Sequencing Sequencing (Sanger) Sequencing (NGS) Sequencing + CNVs (with NGS) Del/Dup (MLPA or qpcr) Carrier
More informationForesight Carrier Screen
Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:
More informationPromo Code (if applicable) ... mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
Genetic Diagnostics A. Analysis Requested 1. Test(s)/Gene(s) 1.1 Single Gene Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis 1.6 Repeat Expansion 1.7
More informationTitle: Assessing Recommendations Related To Timeliness of Newborn Screening
Title: Assessing Recommendations Related To Timeliness of Newborn Screening Purpose: In January 2014, the Secretary s Discretionary Advisory Committee on Heritable Diseases on Newborns and Children (Committee)
More informationJoshua Hellmann Foundation - Newborn Metabolic Screening Program
Joshua Hellmann Foundation - Newborn Metabolic Screening Program Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Last update: 15 February 2016 Target inborn errors of metabolism
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:
More informationPositive Newborn Screens: What do you do next?
Positive Newborn Screens: What do you do next? James B. Gibson, MD, Ph.D. Biochemical Geneticist at Specially for Children Clinical Associate Professor of Pediatrics UTHSCSA Carla R. Scott, MD Pediatric
More informationtheraseek Panel Gene List by Category
theraseek Panel Gene List by Category Gene Pathway/Function Association ACAT1 Alpha-methylacetoacetic aciduria Amino acid metabolism Pathway DHTKD1 Charcot-Marie-Tooth disease 2Q, axonal/2-aminoadipic
More informationHERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
More informationCOMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS
COMMON INHERITED METABOLIC CONDITIONS IN SOUTH AFRICA DIAGNOSING RARE DISEASE IN GENETICALLY UNIQUE AND UNDERSTUDIED POPULATION GROUPS S MELDAU, G VAN DER WATT INHERITED METABOLIC DISEASES GROUP UCT /
More informationLABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS
LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic
More informationNewborn Screening: Focus on Treatment
Newborn Screening: Focus on Treatment Alan R. Fleischman, M.D. Senior Vice President and Medical Director March of Dimes National Conference of State Legislatures July 21, 2008 Newborn Screening: A Public
More informationPatient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
More informationGUIDE TO NEWBORN SCREENING PROGRAMME
\ GUIDE TO NEWBORN SCREENING PROGRAMME 1 MEDILAB PROFILE MEDILAB, the leading independent provider of Clinical Laboratory Diagnostic Services in Cyprus, was established in 1980 by Mr. C. Pavlides and has
More information4978 Santa Anita Ave Temple City, CA (p) (f)
Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:
More informationOverview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy
Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy Alan R. Fleischman, M.D. Senior Vice President and Medical Director Chair, Federal Advisory Committee,
More informationCytogenetic Biochemical
Diagnostic Laboratories Test Menu Molecular Cytogenetic Biochemical Table of Contents Lab Directors & Genetic Counselors...2 Molecular Diagnostic Lab Next Generation Sequencing Panels...3 Biochemical Diagnostic
More informationApproach to diagnosis of metabolic diseases
Translational Science of Rare Diseases 1 (2016) 3 22 DOI 10.3233/TRD-160001 IOS Press 3 Approach to diagnosis of metabolic diseases Enid Gilbert-Barness a,b and Philip M. Farrell c,d, a Department of Pathology,
More informationTRANSAMINATION AND UREA CYCLE
TRANSAMINATION AND UREA CYCLE USMAN SUMO FRIEND TAMBUNAN ARLI ADITYA PARIKESIT SEPTIANA BIOINFORMATICS GROUP DEPARTEMENT OF CHEMISTRY FACULTY OF MATHEMATIC AND SCIENCE UNIVERSITY OF INDONESIA What is transamination?
More informationBeyond the case for NBS in South Africa. Chris Vorster 28/05/2016
Beyond the case for NBS in South Africa Chris Vorster 28/05/2016 The case for NBS in SA Economic justification Cost Utility analysis = Cost/QALY GDP/Capita Immediate implementation (WHO) Political justification
More informationBULGARIAN NATIONAL PLAN. Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD)
BULGARIAN NATIONAL PLAN FOR RARE DISEASES 2009 2013 Associate professor Alexey Savov PhD National Consulting Council for Rare Diseases (NCCRD) Strategy for rare diseases in Bulgaria Project of National
More informationMitochondrial disorders are among the most severe
NEUROLOGY GRAND ROUNDS Leigh Map: A Novel Computational Diagnostic Resource for Mitochondrial Disease Joyeeta Rahman, BSc, 1 Alberto Noronha, MSc, 2 Ines Thiele, PhD, 2 and Shamima Rahman, FRCP, PhD 1,3
More informationClinical Management of Organic Acidemias and OAA Natural History Registry. Kim Chapman MD PhD Children s National Rare Disease Institute
Clinical Management of Organic Acidemias and OAA Natural History Registry Kim Chapman MD PhD Children s National Rare Disease Institute Disclosure Nothing to disclose concerning this lecture Organic acid?
More informationResidual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
More informationCARRIER SCREEN - LIST OF DISORDERS
1 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 2 17-Beta-Hydroxysteroid deyhdrogenase X deficiency 3 2-Methylbutytyrglycinuria 4 21-hydroxylase deficiency 5 3-Methylcrotonyl-CoA carboxylase
More informationRequest for expedited Result
London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory
More informationMEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:
MEDICAL FOODS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are
More informationSupplemental Figure 1
Supplemental Figure 1 mir 26a mir 26b Supplemental Figure 1. Expression of mir-26a is higher than mir-26b in the mouse liver. Dot blot analysis of mir-26a/b expression in the livers of wild-type mice fed
More informationWhole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future?
Whole exome sequencing as a first line test: Is there even a role for metabolic biochemists in the future? Tony Marinakii Purine Research Laboratory Biochemical Sciences Whole exome sequencing No doubt
More informationNewborn Screening & Methods for Diagnosing Inborn Errors of Metabolism
Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism Patricia Jones, PhD DABCC FACB UT Southwestern Medical Center Children s Medical Center Dallas, Texas Learning Objectives Justify
More informationCPT Code and Price List
CPT Code and Price List 2018 CPT Codes Molecular Tests Next Generation Sequencing Panels (2) Sanger Sequencing (3-4) Deletion/Duplication (MLPA) (4) Methylation Analysis (4) Targeted Analysis (4) Trinucleotide
More informationNewborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet
Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet Website:www.tipn.org.tw Telephone:(02)85962050 Ext. 401-403 Service line:(02)85962065 Fax:(02)85962067
More informationNewborn Screening in Manitoba. Information for Health Care Providers
Newborn Screening in Manitoba Information for Health Care Providers Newborn screening: a healthy start leads to a healthier life Health care professionals have provided newborn screening for phenylketonuria
More informationThe Israeli population carrier screening program. Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem
The Israeli population carrier screening program Joël Zlotogora MD, PhD Hadassah medical school Hebrew University Jerusalem The Israeli population 2015 8,134,500 inhabitants Jews (75.1%) Ashkenazi, non
More informationMetabolic Disorders. Chapter Thomson - Wadsworth
Metabolic Disorders Chapter 28 1 Metabolic Disorders Inborn errors of metabolism group of diseases that affect a wide variety of metabolic processes; defective processing or transport of amino acids, fatty
More informationLOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM
LOW CITRULLINE AS A MARKER FOR THE PROXIMAL UREA CYCLE DEFECTS EXPERIENCE OF THE NEW ENGLAND NEWBORN SCREENING PROGRAM Inderneel Sahai, MD, FACMG Newborn Screening and Genetic Testing Symposium Oct 2014
More informationInborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.
Inborn Errors of Metabolism The body is a factory. Inborn errors of metabolism are rare genetic disorders in which the body cannot properly turn food into energy. The disorders are usually caused by defects
More informationRequisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:
Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:
More information[R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS DEPARTMENT OF HEALTH. February October October 1992 (E) September 1995
RULES AND REGULATIONS PERTAINING TO THE NEWBORN METABOLIC, ENDOCRINE, AND HEMOGLOBINOPATHY SCREENING PROGRAM AND THE NEWBORN HEARING LOSS SCREENING PROGRAM [R23-13-MET/HRG] STATE OF RHODE ISLAND AND PROVIDENCE
More informationANNUAL REPORT France 11. Italy 5. Spain 5. Portugal 2. Czech Republic 1. Switzerland 1. Total 25
- 1 - C. VIANEY-SABAN, C. ACQUAVIVA-BOURDAIN Service Maladies Héréditaires du Métabolisme Centre de Biologie et de Pathologie Est 59, Boulevard Pinel 69677 Bron cedex Tel 33 4 72 12 96 94 e-mail christine.saban@chu-lyon.fr
More informationUrea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable
Urea Cycle Disorders and Hyperammonemia: Diagnosable Treatable Screenable Marshall L. Summar, M.D. Chief, Division of Genetics and Metabolism Children s National Medical Center Washington, DC, USA Disclosure
More information2015 Annual Report for New Mexico s Newborn Screening (NBS) Program
2015 Annual Report for New Mexico s Newborn Screening (NBS) Program Sawyer-A Family s Story Inside this Edition A Family Story......1 Why Screen....4 When to Screen...4 What is NBS....5 Screened Conditions..5
More informationBIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona
BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona BIOTIN (BIOTINIDASE) DEFICIENCY biotin in the body is recycled by its removal from carboxylase enzymes to which it is attached
More informationSUPPLEMENTARY,INFORMATIONS,,,, mtorc1,is,required,for,brown,adipose,tissue,recruitment,and, METABOLIC,ADAPTATION,TO,COLD,!! Sébastien!M.!
SUPPLEMENTARY,INFORMATIONS,,,, mtorc,is,required,for,brown,adipose,tissue,recruitment,and, METABOLIC,ADAPTATION,TO,COLD, SébastienM.Labbé,,MathildeMouchiroud,,AlexandreCaron,,BlandineSecco,, Elizaveta
More informationUrea Cycle Defects. Dr Mick Henderson. Biochemical Genetics Leeds Teaching Hospitals Trust. MetBioNet IEM Introductory Training
Urea Cycle Defects Dr Mick Henderson Biochemical Genetics Leeds Teaching Hospitals Trust The Urea Cycle The urea cycle enables toxic ammonia molecules to be converted to the readily excreted and non toxic
More informationIntroduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.
Introduction to Organic Acidemias Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.2014 A Brief Historical Overview Garrod, Archibald E. 1902. The Incidence of
More informationFamily Prep Screen POSITIVE: HIGH REPRODUCTIVE RISK. Cystic Fibrosis
123 Main Street Houston, TX 10231 Phone: (800) 555-1212 Fax: (800) 555-1212 FE Sample Type: OG-510 Saliva Date of Collection: 07/08/2014 Date Received: 07/13/2014 Date Tested: 07/13/2014 Indication: No
More informationMetabolic Muscle Diseases
Metabolic Muscle Diseases Dr Tim Hutchin, Birmingham Children s Hospital Jan 13, 2012 Metabolic myopathies are heterogeneous conditions with defects of muscle energy metabolism that result in predominantly
More informationComprehensive Molecular Testing for Fatty Acid Oxidation Disorders. A Guide for Clinicians
Comprehensive Molecular Testing for Fatty Acid Oxidation Disorders A Guide for Clinicians Cincinnati Children s Hospital Molecular Genetics Laboratory introduces MetaboSeq, our next-generation sequencing
More informationExpanded carrier screening for monogenic disorders: where are we now?
DOI: 10.1002/pd.5109 SPECIAL TOPIC ISSUE ON ADVANCES IN THE DIAGNOSIS OF SINGLE GENE DISORDERS Expanded carrier screening for monogenic disorders: where are we now? Davit Chokoshvili*, Danya Vears and
More information